or Try an Advanced Search...

    Head And Neck Cancer Stocks List

    Symbol Grade Name % Change
    CVM F Cel-Sci Corporation -4.14
    PDSB F PDS Biotechnology Corporation 8.64
    AFMD F Affimed Therapeutics B.V. -2.56
    IOVA F Iovance Biotherapeutics, Inc. 2.27
    LLY F Eli Lilly and Company -0.90
    MNPR C Monopar Therapeutics Inc. 3.32
    ACHL B Achilles Therapeutics plc -0.47
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Cancer Medicine Cancer Immunotherapy Clinical Medicine Immunotherapy Melanoma Solid Tumors Antineoplastic Drugs Biopharmaceutical Cancer Treatment Immune System Immunotherapies Oncology Prostate Cancer Adoptive Cell Transfer Advanced Non Small Cell Lung Cancer Allergies Alzheimer's Disease Amyloid Anal Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Head And Neck Cancer stocks.

    Symbol Grade Name Weight
    IHE D iShares U.S. Pharmaceutical ETF 20.67
    MEDX F Horizon Kinetics Medical ETF 15.83
    THNR F Amplify Weight Loss Drug & Treatment ETF 14.71
    OZEM F Roundhill GLP-1 & Weight Loss ETF 14.13
    XLV D SPDR Select Sector Fund - Health Care 11.9
    View all Head And Neck Cancer ETFs...
    Compare ETFs
    Compare IHE to XLV Compare MEDX to THNR Compare MEDX to XLV

        Head And Neck Cancer Stocks Recent News

        Date Stock Title
        Nov 21 LLY Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
        Nov 21 LLY Eli Lilly, Verge announce milestones in ALS collaboration
        Nov 21 LLY Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
        Nov 20 LLY Jim Cramer on Eli Lilly and Company (LLY): ‘I’m Kind Of Blown Away’
        Nov 20 LLY Eli Lilly in pact with Chinese biotech for novel weight loss therapy
        Nov 20 LLY More companies covering weight loss drugs for their employees
        Nov 20 LLY Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
        Nov 20 LLY China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
        Nov 20 PDSB Down -35.74% in 4 Weeks, Here's Why PDS Biotechnology (PDSB) Looks Ripe for a Turnaround
        Nov 20 LLY Eli Lilly Option Trade Produces $1,125, If You Can Tolerate The Heavy Risk
        Nov 20 LLY Is It Time to Sell Eli Lilly and Pfizer Stocks?
        Nov 20 LLY Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
        Nov 20 LLY The Zacks Analyst Blog Highlights Eli Lilly, PepsiCo and Morgan Stanley
        Nov 20 LLY RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
        Nov 19 AFMD Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
        Nov 19 LLY Lilly announces changes on board of directors
        Nov 19 LLY Top Research Reports for Eli Lilly, PepsiCo & Morgan Stanley
        Nov 19 LLY LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II Study
        Nov 19 LLY Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?
        Nov 19 LLY Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86%
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Cancer Medicine Cancer Immunotherapy Clinical Medicine Immunotherapy Melanoma Solid Tumors Antineoplastic Drugs Biopharmaceutical Cancer Treatment Immune System Immunotherapies Oncology Prostate Cancer Adoptive Cell Transfer Advanced Non Small Cell Lung Cancer Allergies Alzheimer's Disease Amyloid Anal Cancer
        Head And Neck Cancer

        Head and neck cancer is a type of cancer that affects the head and neck region, including the mouth, throat, nose, and salivary glands. It is most commonly caused by smoking, alcohol use, and exposure to certain viruses. Symptoms may include a lump or sore in the mouth, difficulty swallowing, and a persistent sore throat. Treatment may include surgery, radiation, and chemotherapy.

        Browse All Tags